_id
69148d5accc777a4e85d9a9e
Ticker
PHVS
Name
Pharvaris BV
Exchange
NASDAQ
Address
Grafenauweg 8, Zug, Switzerland, 6300
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://pharvaris.com
Description
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist for the treatment of attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), as well as in Phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Last Close
23.98
Volume
291957
Current Price
24.16
Change
0.750625521267722
Last Updated
2025-12-03T12:04:55.987Z
Image
data:image/webp;base64,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
Ipo Date
2021-02-05T00:00:00.000Z
Market Cap
1566822144
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9925833333333335
Sentiment Sources
12
Rating
4.4444
Target Price
37.8857
Strong Buy
6
Buy
2
Hold
0
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
39664499
Operating Income
-39664499
Interest Expense
-
Pretax Income
-37318504
Net Income
-37137035
Eps
-0.5965214944464459
Dividends Per Share
-
Shares Outstanding
64959454
Income Tax Expense
-181469
EBITDA
-37213352
Operating Margin
-
Total Other Income Expense Net
2345995
Cash
329285629
Short Term Investments
-
Receivables
2937149
Inventories
-
Total Current Assets
337186924
Property Plant Equipment
1251420
Total Assets
338896201
Payables
2548047
Short Term Debt
137617
Long Term Debt
-
Total Liabilities
26655561
Equity
312240640
Depreciation
105152
Change In Working Capital
1845562
Cash From Operations
-30668913
Capital Expenditures
18714
Cash From Investing
-18714
Cash From Financing
160434075
Net Change In Cash
129713944
PE
-
PB
4.817132933368315
ROE
-11.893722418708851
ROA
-10.958232901524912
FCF
-30687627
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
39664499
Quarters > 0 > income Statement > operating Income
-39664499
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-37318504
Quarters > 0 > income Statement > net Income
-37137035
Quarters > 0 > income Statement > eps
-0.5965214944464459
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
62255988
Quarters > 0 > income Statement > income Tax Expense
-181469
Quarters > 0 > income Statement > EBITDA
-37213352
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2345995
Quarters > 0 > balance Sheet > cash
329285629
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2937149
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
337186924
Quarters > 0 > balance Sheet > property Plant Equipment
1251420
Quarters > 0 > balance Sheet > total Assets
338896201
Quarters > 0 > balance Sheet > payables
2548047
Quarters > 0 > balance Sheet > short Term Debt
137617
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
26655561
Quarters > 0 > balance Sheet > equity
312240640
Quarters > 0 > cash Flow > net Income
-37318504
Quarters > 0 > cash Flow > depreciation
105152
Quarters > 0 > cash Flow > change In Working Capital
1845562
Quarters > 0 > cash Flow > cash From Operations
-30668913
Quarters > 0 > cash Flow > capital Expenditures
18714
Quarters > 0 > cash Flow > cash From Investing
-18714
Quarters > 0 > cash Flow > cash From Financing
160434075
Quarters > 0 > cash Flow > net Change In Cash
129713944
Quarters > 0 > ratios > PE
-0.5965214944464459
Quarters > 0 > ratios > PB
4.817132933368315
Quarters > 0 > ratios > ROE
-11.893722418708851
Quarters > 0 > ratios > ROA
-10.958232901524912
Quarters > 0 > ratios > FCF
-30687627
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
40373097
Quarters > 1 > income Statement > operating Income
-40373097
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-45277904
Quarters > 1 > income Statement > net Income
-45480686
Quarters > 1 > income Statement > eps
-0.831636458494817
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
54688182
Quarters > 1 > income Statement > income Tax Expense
202782
Quarters > 1 > income Statement > EBITDA
-40270065
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-4904807
Quarters > 1 > balance Sheet > cash
199571685
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2597208
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
208173846
Quarters > 1 > balance Sheet > property Plant Equipment
1338607
Quarters > 1 > balance Sheet > total Assets
209810326
Quarters > 1 > balance Sheet > payables
4859249
Quarters > 1 > balance Sheet > short Term Debt
161544
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
25474434
Quarters > 1 > balance Sheet > equity
184335892
Quarters > 1 > cash Flow > net Income
-45277904
Quarters > 1 > cash Flow > depreciation
103032
Quarters > 1 > cash Flow > change In Working Capital
3197133
Quarters > 1 > cash Flow > cash From Operations
-29980358
Quarters > 1 > cash Flow > capital Expenditures
16636
Quarters > 1 > cash Flow > cash From Investing
16636
Quarters > 1 > cash Flow > cash From Financing
-22900
Quarters > 1 > cash Flow > net Change In Cash
-36924252
Quarters > 1 > ratios > PE
-0.831636458494817
Quarters > 1 > ratios > PB
7.167711414117876
Quarters > 1 > ratios > ROE
-24.67272407264018
Quarters > 1 > ratios > ROA
-21.67704844040898
Quarters > 1 > ratios > FCF
-29996994
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
97024
Quarters > 2 > income Statement > gross Profit
-97024
Quarters > 2 > income Statement > operating Expenses
-42186311
Quarters > 2 > income Statement > operating Income
42186311
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-46038156
Quarters > 2 > income Statement > net Income
-46340823
Quarters > 2 > income Statement > eps
-0.8499940020910142
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
54519000
Quarters > 2 > income Statement > income Tax Expense
302667
Quarters > 2 > income Statement > EBITDA
-42081010
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-88224467
Quarters > 2 > balance Sheet > cash
236495937
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2643284
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
246180910
Quarters > 2 > balance Sheet > property Plant Equipment
1510810
Quarters > 2 > balance Sheet > total Assets
248064041
Quarters > 2 > balance Sheet > payables
4225946
Quarters > 2 > balance Sheet > short Term Debt
194599
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
22725098
Quarters > 2 > balance Sheet > equity
225338943
Quarters > 2 > cash Flow > net Income
-46038156
Quarters > 2 > cash Flow > depreciation
105301
Quarters > 2 > cash Flow > change In Working Capital
-2289920
Quarters > 2 > cash Flow > cash From Operations
-38471605
Quarters > 2 > cash Flow > capital Expenditures
161003
Quarters > 2 > cash Flow > cash From Investing
-161003
Quarters > 2 > cash Flow > cash From Financing
-75447
Quarters > 2 > cash Flow > net Change In Cash
-44232100
Quarters > 2 > ratios > PE
-0.8499940020910142
Quarters > 2 > ratios > PB
5.84532359326812
Quarters > 2 > ratios > ROE
-20.56494203045942
Quarters > 2 > ratios > ROA
-18.680991736323442
Quarters > 2 > ratios > FCF
-38632608
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
45092034
Quarters > 3 > income Statement > operating Income
-45092034
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-33521747
Quarters > 3 > income Statement > net Income
-34760940
Quarters > 3 > income Statement > eps
-0.6392288592771124
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
54379491
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
10275602
Quarters > 3 > balance Sheet > cash
280728037
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
289419576
Quarters > 3 > balance Sheet > property Plant Equipment
1480842
Quarters > 3 > balance Sheet > total Assets
291374765
Quarters > 3 > balance Sheet > payables
4562900
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
23614024
Quarters > 3 > balance Sheet > equity
267760741
Quarters > 3 > cash Flow > net Income
-34760940
Quarters > 3 > cash Flow > depreciation
90958
Quarters > 3 > cash Flow > change In Working Capital
3917489
Quarters > 3 > cash Flow > cash From Operations
-34953682
Quarters > 3 > cash Flow > capital Expenditures
160917
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
566162
Quarters > 3 > cash Flow > net Change In Cash
-34548437
Quarters > 3 > ratios > PE
-0.6392288592771124
Quarters > 3 > ratios > PB
4.906650981220581
Quarters > 3 > ratios > ROE
-12.982089857601641
Quarters > 3 > ratios > ROA
-11.929976159740532
Quarters > 3 > ratios > FCF
-35114599
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
37
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
145688167
Annuals > 0 > income Statement > operating Income
-145688167
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-132396000
Annuals > 0 > income Statement > net Income
-134221000
Annuals > 0 > income Statement > eps
-2.484607837692749
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
54021000
Annuals > 0 > income Statement > income Tax Expense
1825024
Annuals > 0 > income Statement > EBITDA
-145593000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
13292167
Annuals > 0 > balance Sheet > cash
280728037
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2944514
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
289419576
Annuals > 0 > balance Sheet > property Plant Equipment
1480842
Annuals > 0 > balance Sheet > total Assets
291374765
Annuals > 0 > balance Sheet > payables
4562900
Annuals > 0 > balance Sheet > short Term Debt
222427
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
23614024
Annuals > 0 > balance Sheet > equity
267760741
Annuals > 0 > cash Flow > net Income
-132396503
Annuals > 0 > cash Flow > depreciation
269562
Annuals > 0 > cash Flow > change In Working Capital
5889958
Annuals > 0 > cash Flow > cash From Operations
-120130191
Annuals > 0 > cash Flow > capital Expenditures
538086
Annuals > 0 > cash Flow > cash From Investing
-538086
Annuals > 0 > cash Flow > cash From Financing
2676555
Annuals > 0 > cash Flow > net Change In Cash
-110503600
Annuals > 0 > ratios > PE
-2.484607837692749
Annuals > 0 > ratios > PB
4.866234367046363
Annuals > 0 > ratios > ROE
-50.12721413106637
Annuals > 0 > ratios > ROA
-46.06473041685679
Annuals > 0 > ratios > FCF
-120668277
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
252271
Annuals > 1 > income Statement > gross Profit
-252271
Annuals > 1 > income Statement > operating Expenses
96913620
Annuals > 1 > income Statement > operating Income
-96913620
Annuals > 1 > income Statement > interest Expense
20055
Annuals > 1 > income Statement > pretax Income
-99826263
Annuals > 1 > income Statement > net Income
-100875068
Annuals > 1 > income Statement > eps
-2.6275259721813495
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
38391654
Annuals > 1 > income Statement > income Tax Expense
1048805
Annuals > 1 > income Statement > EBITDA
-96656069
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-2912643
Annuals > 1 > balance Sheet > cash
391231637
Annuals > 1 > balance Sheet > short Term Investments
322558
Annuals > 1 > balance Sheet > receivables
1039024
Annuals > 1 > balance Sheet > inventories
-322558
Annuals > 1 > balance Sheet > total Current Assets
397851365
Annuals > 1 > balance Sheet > property Plant Equipment
455571
Annuals > 1 > balance Sheet > total Assets
398694465
Annuals > 1 > balance Sheet > payables
2909725
Annuals > 1 > balance Sheet > short Term Debt
195341
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
14646062
Annuals > 1 > balance Sheet > equity
384048403
Annuals > 1 > cash Flow > net Income
-99826263
Annuals > 1 > cash Flow > depreciation
257551
Annuals > 1 > cash Flow > change In Working Capital
-5862655
Annuals > 1 > cash Flow > cash From Operations
-93049093
Annuals > 1 > cash Flow > capital Expenditures
89984
Annuals > 1 > cash Flow > cash From Investing
-89984
Annuals > 1 > cash Flow > cash From Financing
325393000
Annuals > 1 > cash Flow > net Change In Cash
229394208
Annuals > 1 > ratios > PE
-2.6275259721813495
Annuals > 1 > ratios > PB
2.4111718399203967
Annuals > 1 > ratios > ROE
-26.266238112699558
Annuals > 1 > ratios > ROA
-25.301346483453184
Annuals > 1 > ratios > FCF
-93139077
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
150186
Annuals > 2 > income Statement > gross Profit
-150186
Annuals > 2 > income Statement > operating Expenses
86714608
Annuals > 2 > income Statement > operating Income
-86714608
Annuals > 2 > income Statement > interest Expense
16105
Annuals > 2 > income Statement > pretax Income
-75653470
Annuals > 2 > income Statement > net Income
-76332557
Annuals > 2 > income Statement > eps
-2.272750894599579
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
33585976
Annuals > 2 > income Statement > income Tax Expense
679087
Annuals > 2 > income Statement > EBITDA
-86561667
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
11061138
Annuals > 2 > balance Sheet > cash
161837429
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
382468
Annuals > 2 > balance Sheet > inventories
4044255
Annuals > 2 > balance Sheet > total Current Assets
166846741
Annuals > 2 > balance Sheet > property Plant Equipment
626439
Annuals > 2 > balance Sheet > total Assets
167732983
Annuals > 2 > balance Sheet > payables
5979168
Annuals > 2 > balance Sheet > short Term Debt
187404
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
18473953
Annuals > 2 > balance Sheet > equity
149259030
Annuals > 2 > cash Flow > net Income
-75653470
Annuals > 2 > cash Flow > depreciation
152941
Annuals > 2 > cash Flow > change In Working Capital
8376900
Annuals > 2 > cash Flow > cash From Operations
-67162634
Annuals > 2 > cash Flow > capital Expenditures
124296
Annuals > 2 > cash Flow > cash From Investing
-124296
Annuals > 2 > cash Flow > cash From Financing
8650368
Annuals > 2 > cash Flow > net Change In Cash
-47515703
Annuals > 2 > ratios > PE
-2.272750894599579
Annuals > 2 > ratios > PB
5.427435386120358
Annuals > 2 > ratios > ROE
-51.14099763344302
Annuals > 2 > ratios > ROA
-45.50837625060302
Annuals > 2 > ratios > FCF
-67286930
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
80456
Annuals > 3 > income Statement > gross Profit
-80456
Annuals > 3 > income Statement > operating Expenses
54138626
Annuals > 3 > income Statement > operating Income
-54138626
Annuals > 3 > income Statement > interest Expense
278181
Annuals > 3 > income Statement > pretax Income
-42660662
Annuals > 3 > income Statement > net Income
-42730779
Annuals > 3 > income Statement > eps
-1.4050676277991425
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
30411902
Annuals > 3 > income Statement > income Tax Expense
70117
Annuals > 3 > income Statement > EBITDA
-54061256
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
11477964
Annuals > 3 > balance Sheet > cash
209353132
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
700079
Annuals > 3 > balance Sheet > inventories
1507753
Annuals > 3 > balance Sheet > total Current Assets
211566663
Annuals > 3 > balance Sheet > property Plant Equipment
351349
Annuals > 3 > balance Sheet > total Assets
212090065
Annuals > 3 > balance Sheet > payables
2125511
Annuals > 3 > balance Sheet > short Term Debt
99432
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7136995
Annuals > 3 > balance Sheet > equity
204953070
Annuals > 3 > cash Flow > net Income
-42660662
Annuals > 3 > cash Flow > depreciation
77370
Annuals > 3 > cash Flow > change In Working Capital
1575305
Annuals > 3 > cash Flow > cash From Operations
-44599684
Annuals > 3 > cash Flow > capital Expenditures
130032
Annuals > 3 > cash Flow > cash From Investing
-130032
Annuals > 3 > cash Flow > cash From Financing
143671339
Annuals > 3 > cash Flow > net Change In Cash
110724261
Annuals > 3 > ratios > PE
-1.4050676277991425
Annuals > 3 > ratios > PB
3.5790392221985257
Annuals > 3 > ratios > ROE
-20.849055347158256
Annuals > 3 > ratios > ROA
-20.1474684823167
Annuals > 3 > ratios > FCF
-44729716
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.5965214944464459
Valuation > metrics > PB
4.817132933368315
Valuation > final Score
31.82867066631685
Valuation > verdict
60.6% Overvalued
Profitability > metrics > ROE
-11.893722418708851
Profitability > metrics > ROA
-11.013782669698069
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08536864707938083
Risk > metrics > Interest Coverage
-377.2110753956178
Risk > final Score
-1449
Risk > verdict
High
Liquidity > metrics > Current Ratio
125.55067350197196
Liquidity > metrics > Quick Ratio
125.55067350197196
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
21.546764067318804
Prev Valuations > 2
30.933490187794188
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
28
Prev Risks > 1
100
Prev Risks > 2
42
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:01:03.975Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-14
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.6418
Earnings History > 0 > eps Difference
0.6418
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.6
Earnings History > 1 > eps Estimate
-0.6755
Earnings History > 1 > eps Difference
0.0755
Earnings History > 1 > surprise Percent
11.1769
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-12
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.83
Earnings History > 2 > eps Estimate
-0.7686
Earnings History > 2 > eps Difference
-0.0614
Earnings History > 2 > surprise Percent
-7.9886
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.64
Earnings History > 3 > eps Estimate
-0.7215
Earnings History > 3 > eps Difference
0.0815
Earnings History > 3 > surprise Percent
11.2959
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.64
Earnings History > 4 > eps Estimate
-0.7265
Earnings History > 4 > eps Difference
0.0865
Earnings History > 4 > surprise Percent
11.9064
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.77
Earnings History > 5 > eps Estimate
-0.5921
Earnings History > 5 > eps Difference
-0.1779
Earnings History > 5 > surprise Percent
-30.0456
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-05
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.6
Earnings History > 6 > eps Estimate
-0.58
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-3.4483
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.52
Earnings History > 7 > eps Estimate
-0.56
Earnings History > 7 > eps Difference
0.04
Earnings History > 7 > surprise Percent
7.1429
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-06
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.82
Earnings History > 8 > eps Estimate
-0.58
Earnings History > 8 > eps Difference
-0.24
Earnings History > 8 > surprise Percent
-41.3793
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-02
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.58
Earnings History > 9 > eps Estimate
-0.6
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
3.3333
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-07
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.63
Earnings History > 10 > eps Estimate
-0.65
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
3.0769
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-04-05
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-1.17
Earnings History > 11 > eps Estimate
-0.65
Earnings History > 11 > eps Difference
-0.52
Earnings History > 11 > surprise Percent
-80
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2022-12-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-1.25
Earnings History > 12 > eps Estimate
-0.7
Earnings History > 12 > eps Difference
-0.55
Earnings History > 12 > surprise Percent
-78.5714
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-12-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.25
Earnings History > 13 > eps Estimate
-0.63
Earnings History > 13 > eps Difference
0.38
Earnings History > 13 > surprise Percent
60.3175
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-09-12
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.38
Earnings History > 14 > eps Estimate
-0.57
Earnings History > 14 > eps Difference
0.19
Earnings History > 14 > surprise Percent
33.3333
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-11
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.48
Earnings History > 15 > eps Estimate
-0.49
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
2.0408
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-29
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.09
Earnings History > 16 > eps Estimate
-0.71
Earnings History > 16 > eps Difference
0.62
Earnings History > 16 > surprise Percent
87.3239
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.39
Earnings History > 17 > eps Estimate
-0.42
Earnings History > 17 > eps Difference
0.03
Earnings History > 17 > surprise Percent
7.1429
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-30
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.94
Earnings History > 18 > eps Estimate
-0.39
Earnings History > 18 > eps Difference
-0.55
Earnings History > 18 > surprise Percent
-141.0256
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-29
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-2.18
Earnings History > 19 > eps Estimate
-1.19
Earnings History > 19 > eps Difference
-0.99
Earnings History > 19 > surprise Percent
-83.1933
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-09
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-2.65
Earnings History > 20 > eps Estimate
-1.39
Earnings History > 20 > eps Difference
-1.26
Earnings History > 20 > surprise Percent
-90.6475
Earnings History > 21 > period
2019-09-30
Earnings History > 21 > report Date
2019-12-31
Earnings History > 21 > date
2019-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.7999
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.7999
Earnings History > 21 > surprise Percent
-
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist for the treatment of attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), as well as in Phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APharvaris (NasdaqGS:PHVS): Reassessing Valuation After RAPIDe-3 Phase 3 Success and Deucrictibant Commercial Progress simplywall.st
Read more →Pharvaris (NASDAQ:PHVS) Rating Lowered to Sell at Wall Street Zen Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$37.8857
Analyst Picks
Strong Buy
6
Buy
2
Hold
0
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 10.31% of the total shares of Pharvaris BV
1.
Fidelity Growth Compy Commingled Pl S(2.6882%)
since
2025/07/31
2.
Fidelity Growth Company Fund(1.9686%)
since
2025/07/31
3.
Fidelity Select Health Care(1.1961%)
since
2025/07/31
4.
Fidelity Small Cap Growth(1.1323%)
since
2025/06/30
5.
Fidelity Advisor Health Care I(0.7701%)
since
2025/07/31
6.
Fidelity Growth Company K6(0.5985%)
since
2025/07/31
7.
Fidelity Series Growth Company(0.5575%)
since
2025/07/31
8.
Fidelity Small Cap Growth K6(0.4318%)
since
2025/06/30
9.
Fidelity VIP Health Care Initial(0.1762%)
since
2025/07/31
10.
Fidelity Select Biotechnology(0.1638%)
since
2025/07/31
11.
iShares MSCI EAFE Small-Cap ETF(0.1141%)
since
2025/08/31
12.
iShares Core MSCI EAFE ETF(0.0858%)
since
2025/08/31
13.
State St Gbl Sm Cp Eq ex-US Indx NL Cl A(0.0736%)
since
2025/08/31
14.
iShares MSCI EMU Small Cap ETF EUR Acc(0.0655%)
since
2025/08/31
15.
Xtrackers MSCI Eur Small Cap ETF 1C(0.064%)
since
2025/07/31
16.
Amundi MSCI EMU SmCapESGBrdTrnstnETFDIS(0.0624%)
since
2025/08/29
17.
Fidelity Nasdaq Composite Index(0.0533%)
since
2025/07/31
18.
UBS MSCI EMU Small Cap ETF EUR dis(0.0428%)
since
2025/08/29
19.
iShares MSCI Netherlands ETF(0.0373%)
since
2025/08/31
20.
Nationwide International Sm Cp R6(0.0305%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
-0.6418
Date
2025-09-30
EPS Actual
-0.6
EPS Estimate
-0.6755
EPS Difference
0.0755
Surprise Percent
11.1769%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.